Recent Quotes (30 days)

You have no recent quotes
chg | %

Strategic Diagnostics Inc.  

(Public, NASDAQ:SDIX)   Watch this stock  
Find more results for SDIX
1.02
+0.01 (0.99%)
May 24 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 1.01 - 1.06
52 week 0.87 - 1.85
Open 1.01
Vol / Avg. 4,707.00/32,504.00
Mkt cap 21.41M
P/E     -
Div/yield     -
EPS -0.34
Shares 20.99M
Beta 0.81
Inst. own 44%
Mar 18, 2013
Q4 2012 Strategic Diagnostics Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '12) 2011
Net profit margin -43.05% -19.72%
Operating margin -42.93% -19.46%
EBITD margin - -14.41%
Return on average assets -34.10% -21.14%
Return on average equity -39.97% -24.03%
Employees 143 -
Carbon Disclosure Rating - -

Address

111 Pencader Drive
NEWARK, DE 19702
United States - Map
+1-302-4566789 (Phone)
+1-302-4566770 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Discussion Group - Google Finance

Description

Strategic Diagnostics Inc. (SDIX) is a biotechnology company. The Company is engaged in developing, commercializing and marketing products and solutions that preserve human health and wellness. The Company's business is focused in two areas: Life Sciences and Kit Products. The Company's Food Safety portfolio includes immunoassays, which represent technology detection of food pathogens. SDIX's RapidChek and SELECT test kits are experiencing growing used for the detection of pathogens, such as E. coli, Salmonella and Listeria in the production, processing and manufacturing of food. The Company serves the pharmaceutical, biotechnology, diagnostics and food safety markets. In December 2011, Modern Water Plc acquired the water quality division of Strategic Diagnostics Inc.

Officers and directors

Thomas A. Bologna Independent Chairman of the Board
Age: 64
Bio & Compensation  - Reuters
Francis M. DiNuzzo President, Chief Executive Officer, Director
Age: 56
Bio & Compensation  - Reuters
Kevin J. Bratton Chief Financial Officer, Vice President - Finance, Corporate Secretary
Age: 63
Bio & Compensation  - Reuters
Steven R. Becker Independent Director
Age: 45
Bio & Compensation  - Reuters
C. Geoffrey Davis Ph.D. Independent Director
Age: 61
Bio & Compensation  - Reuters
Richard A. van den Broek Independent Director
Age: 47
Bio & Compensation  - Reuters
Stephen L. Waechter Independent Director
Age: 61
Bio & Compensation  - Reuters
David M. Wurzer CPA Independent Director
Age: 53
Bio & Compensation  - Reuters